Aproxen

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Aproxen

Quick Facts

Property Description
Active ingredient Naproxen Sodium
Form Oral tablets, caplets, or suspension
Pharmacological class Nonsteroidal Anti-inflammatory Drug (NSAID)
Common use Relief from pain, inflammation, and fever
Origin Synthetic

What is Aproxen and Its Chemical Identity?

Aproxen is a medicinal product defined by its active ingredient, Naproxen Sodium. It is a synthetic, single-ingredient product administered via the oral route, and is fundamentally classified as a Nonsteroidal Anti-inflammatory Drug (NSAID).

Chemically, Naproxen Sodium is a Propionic acid derivative, a family of compounds whose anti-inflammatory activity is clinically recognized for systemic action. The substance is the sodium salt form of naproxen, which facilitates its absorption compared to the base acid form. Naproxen Sodium belongs to the COX inhibitor class, which modifies the inflammatory response.


Classification: Analgesic, Anti-inflammatory, and Antipyretic Agent

The general purpose of Aproxen is to provide symptomatic relief across three primary functions: reducing pain, lowering fever, and easing inflammation. This combined capability makes it an effective analgesic, antipyretic, and anti-inflammatory agent.

This mechanism is rooted in its inhibition of prostaglandins—key chemicals in the body that signal pain and mediate the inflammatory cascade. Naproxen is used to relieve pain from various conditions and to reduce fever. This systemic approach contrasts with localized treatments, offering comprehensive control over discomfort such as general body aches or mild inflammatory stiffness.


Common Drug Forms of Naproxen Sodium

The active ingredient is designed for oral administration and is typically presented as a solid or liquid preparation, including standard tablets, caplets, and oral suspension.

To modify the rate and location of drug release, the medicine may also be formulated as enteric-coated tablets, designed to bypass the stomach before dissolving, or extended-release tablets, engineered to prolong the duration of action. These variations in physical form define the specific product variant but consistently deliver the core pharmacological action of the Naproxen Sodium compound.

Regulatory References

  1. NIH MedlinePlus Drug Information on Naproxen
  2. Naproxen: MedlinePlus Drug Information

What side effects are possible with Aproxen?

Possible Side Effects and Safety Information

The safety profile of Aproxen (naproxen sodium), as defined by governmental health authorities, is structured around the potential for common, expected adverse reactions and rare, serious, clinically significant events.

Adverse Reaction Scope

Classification/System Documented Effects
Most Common Reactions Abdominal pain, dyspepsia (indigestion), nausea, headache, dizziness, rash, and peripheral edema (fluid retention) [Source 1.1].
System-Organ Classes Effects primarily involve Gastrointestinal (ulceration, bleeding), Cardiovascular (MI, stroke, hypertension), Nervous System, Renal, and Hepatobiliary systems [Source 1.2, 2.7].
Serious Adverse Reactions Serious Cardiovascular Thrombotic Events (including fatal myocardial infarction and stroke); Serious Gastrointestinal Events (including bleeding, ulceration, and perforation, which can be fatal); and Severe Hypersensitivity Reactions (e.g., anaphylaxis, Stevens-Johnson Syndrome) [Source 1.1, 1.2].

Safety Constraints and Considerations

  • Dose- and Duration-Related Patterns: The official regulatory labeling states that the risk of serious CV and GI adverse events increases with higher doses and longer duration of use [Source 1.1, 1.2].
  • Population-Specific Restrictions: The medicine is contraindicated for the management of pain in the setting of Coronary Artery Bypass Graft (CABG) surgery [Source 1.1]. Caution is advised for older adults, who have an increased risk of severe GI events. Use is generally avoided in pregnant individuals at or after 20 weeks gestation due to the risk of fetal harm [Source 1.3, 1.4].
  • Other Restrictions: Aproxen is contraindicated in patients with a history of asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs [Source 1.2]. It is documented to potentially cause or worsen hypertension and can mask signs of underlying conditions like fever or infection [Source 1.6, 2.1].

This official safety information establishes that the primary risks are rare but serious systemic events, which contrasts with the more common, non-serious GI and neurological effects. The specific warnings and contraindications define the conditions under which the medicine's use is officially restricted.

Overdose and Emergency Response

Overdose and when to seek help

An overdose of Aproxen (Naproxen/Naproxen Sodium) occurs when an individual takes more than the recommended amount. The ingestion of a large amount may increase the potential for serious effects, although an overdose is often considered mild.

Documented Overdose Manifestations

Symptoms reported in cases of overdose typically involve the gastrointestinal (GI) and central nervous systems. Common acute manifestations may include extreme tiredness, drowsiness, stomach pain, heartburn, nausea, and vomiting. Less common but potentially serious signs following large ingestions are altered mental status, coma, seizures, GI tract bleeding, and kidney failure.

When to Seek Urgent Medical Attention

Immediate emergency medical attention is required if you suspect an overdose, even if no symptoms are present. Contact a Poison Control Center or emergency medical services right away. You must stop taking Aproxen and seek immediate medical help if you experience:

  • Bloody or black, tarry stools or vomit that looks like coffee grounds.
  • Shortness of breath, wheezing, or any trouble breathing.
  • Skin rash, hives, or swelling of the face/throat.
  • Any change in the amount or color of your urine.

Individuals who are elderly or have pre-existing conditions, particularly kidney or liver disease, may be at higher risk for serious complications following excessive exposure.

Therapeutic Uses of Aproxen

Aproxen, which contains Naproxen Sodium, is commonly used to provide symptomatic relief by addressing symptoms related to physical discomfort, inflammation, and fever. It is applied across clinical settings that involve acute or disruptive symptom patterns, such as those related to inflammatory or irritative states.

Symptomatic Relief Domains

The medication is relevant for easing discomfort across several domains, including the management of chronic inflammatory joint conditions like Osteoarthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis; addressing acute musculoskeletal pain from conditions such as Bursitis, Tendinitis, or sprains; and providing relief for specific episodes like Primary Dysmenorrhea (menstrual cramps) and Acute Gouty Arthritis attacks. It helps manage symptom clusters that interfere with daily comfort. The intent of therapeutic use is supportive relief, which assists with easing physical discomfort during periods of heightened symptoms.


Quick Fact: Relief for Inflammatory Discomfort

Property Description
Main Use Symptomatic relief for pain, inflammation, and fever
Typical Contexts Chronic joint disease flare-ups, acute injury, cyclical pain episodes
Primary Benefit Easing overall symptom load; supports day-to-day comfort

Regulatory References

  1. NIH MedlinePlus overview of Naproxen Sodium

Eligibility and Restrictions for Use

Aproxen (Naproxen Sodium) eligibility is strictly defined by regulatory guidelines, classifying populations into approved, restricted, and contraindicated groups. The medicine is contraindicated for patients with a known history of allergic-type reactions (such as asthma or urticaria) to aspirin or other NSAIDs. Absolute prohibitions also apply to patients with severe hepatic, renal, or heart failure, those who have undergone Coronary Artery Bypass Graft (CABG) surgery, and any patient experiencing active gastrointestinal bleeding or recurrent ulcers.

Use is strictly contraindicated during the third trimester of pregnancy (after 30 weeks gestation). Eligibility is age-dependent: use is not established for most formulations in children under two years of age. Older adults may be eligible but are advised to use the lowest effective dose for the shortest duration due to increased sensitivity and risk of adverse effects. Furthermore, use is generally not recommended for women who are actively trying to conceive, or for patients with advanced, non-dialysis dependent kidney disease.

What should I know about interactions with other medicines?

Aproxen (Naproxen Sodium) has officially documented interaction patterns based on regulatory analysis that primarily involve changes in drug exposure and additive pharmacodynamic risks.

Contraindicated and Restricted Combinations

Co-administration with other Nonsteroidal Anti-inflammatory Drugs (NSAIDs) and analgesic doses of aspirin is generally not recommended in regulatory labeling due to the increased, cumulative risk of serious adverse events. The combination of Aproxen with Alcohol may also increase the risk of stomach bleeding.

Pharmacodynamic and Pharmacokinetic Interactions

Regulatory documentation describes key interactions resulting from altered drug clearance or additive effects:

Interacting Substance/Class Documented Interaction Outcome
Anticoagulants (Warfarin, Heparin) Enhances effects, increasing the risk of hemorrhage.
Oral Corticosteroids / Anti-Platelet Agents Increases the risk of gastrointestinal bleeding and ulceration.
Anti-hypertensives (ACE Inhibitors, ARBs) Diminishes the therapeutic effect of these medications.
Lithium, Digoxin, Methotrexate Increases plasma concentrations due to inhibition of renal clearance, potentially enhancing toxicity.

Timing and Population Notes

A mandatory timing rule applies to Mifepristone: Aproxen must not be used for 8–12 days after administration to avoid reducing the effect of Mifepristone. For elderly patients, official labeling notes an increased unbound plasma fraction of naproxen. The combination with ACE Inhibitors or ARBs may result in deterioration of renal function in high-risk groups, such as the elderly or those with impaired renal function.

Mechanism of Action

Enzyme Inhibition and Prostaglandin Suppression

The fundamental mechanism involves the nonselective, competitive inhibition of two key enzymes, Cyclooxygenase-1 ( COX-1) and Cyclooxygenase-2 ( COX-2). By blocking these enzymes, the drug suppresses the synthesis of Prostaglandins ( PGE2) and other prostanoids from Arachidonic Acid, which are potent chemical mediators within the nociceptive and inflammatory signaling pathways.

Modulation of Central and Peripheral Signaling

The reduction in PGE2 levels exerts simultaneous effects on distinct physiological systems. In peripheral tissues and the spinal cord, reduced PGE2 diminishes the sensitization of pain receptors, which reduces the magnitude of nociceptor signaling. In the brain's hypothalamic thermoregulatory center, this action modulates the PGE2 influence on the body's thermoregulatory set point.

Mechanistic Constraint and Specificity

As a consequence of its nonselective action, the drug also temporarily inhibits COX-1 in platelets, suppressing Thromboxane A2 ( TXA2) synthesis, which interferes with platelet aggregation. This reversible inhibition profile is key to understanding the drug's functional consequence on continuously running physiological processes. This mechanism inherently involves both constitutive ( COX-1) and inducible ( COX-2) enzymatic activity.

Dosage and Administration Information

Official Administration Protocol

Aproxen, containing Naproxen Sodium, is strictly intended for oral administration in all approved forms, including immediate-release, delayed-release, and oral suspension. The overall approach to use is governed by the regulatory principle of utilizing the lowest effective dose for the shortest duration necessary to manage symptoms.

Dosing and Frequency

For the long-term management of chronic inflammatory conditions, the typical daily dose ranges from 500 mg to 1000 mg (naproxen base), often prescribed in two divided doses. For acute episodes, the initial dose may be higher (500 mg to 550 mg), followed by smaller doses at 6 to 12-hour intervals, not to exceed the maximum daily limit of 1000 mg (naproxen base) after the first day.

Contextual Use and Handling

All oral forms are advised to be taken with or after food or milk, swallowed with a full glass of water. A critical instruction for delayed-release and extended-release tablets is that they must be swallowed whole and must not be crushed, broken, or chewed, as this compromises the intended drug release profile. Official guidelines emphasize dose adjustment for certain populations; for instance, the medicine is not recommended for use in patients with moderate to severe renal impairment.

Recent Clinical Evidence

Aproxen: Recent Clinical Evidence

Overview of Research Focus

Research has explored whether the drug's activity impacts patient outcomes, and some research has explored whether a difference exists in therapeutic outcomes. Studies have generally focused on the drug's effect on target biomarkers, with various trials exploring the clinical implications of these findings.


Key Research Findings

Symptom Management

Studies examined the effect of the drug on symptom measures. A Phase III trial evaluated changes in symptom severity. The trial explored the drug's impact over a 12-month period, focusing on established clinical endpoints. Researchers evaluated the drug's effect on key inflammatory markers. Researchers evaluated the drug's effect on pain and discomfort measures.

Quality of Life

Long-term studies examined measures of symptom onset and changes in quality of life scores. Findings have been mixed, with some research evaluated whether the drug affects a patient's daily activity level over time. Further investigation is needed to draw clearer conclusions.


Special Populations and Safety Parameters

Safety Parameters

Studies explored specific safety parameters.

Usage in Specific Groups

Studies evaluated the drug's effect in elderly patients. Studies evaluated the drug's effect in this group. Available evidence regarding pediatric use is limited.


Research on Combination Therapy

Research compared the effect of the drug in combination with Drug B versus the drug alone. These studies aimed to evaluate whether combination treatment resulted in different outcomes for specific clinical measures. Preliminary evidence from Phase II trials is being reviewed in the context of Drug B to inform larger-scale studies.

Key Studies & References

  1. Meta-analysis of the efficacy and safety of naproxen sodium in the acute treatment of migraine - Database of Abstracts of Reviews of Effects (DARE)

Frequently Asked Questions (FAQ)

Common questions about Aproxen (FAQ)


Q: What is the main difference between Aproxen and Aproxen Sodium?

A: Aproxen Sodium is defined in product labeling as the sodium salt form of the active ingredient Naproxen. Official product information states that the sodium salt facilitates a faster absorption is generally observed in the body compared to the plain acid form.


Q: Is Aproxen considered a strong painkiller?

A: Official classification defines Aproxen as a Nonsteroidal Anti-inflammatory Drug (NSAID). It is approved for the relief of mild to moderate pain, in addition to reducing fever and inflammation. Aproxen is classified as an NSAID, which provides relief through its anti-inflammatory mechanism.


Q: How long does it usually take for Aproxen to start working for acute pain?

A: Regulatory information indicates that for the standard immediate-release forms of Aproxen, the medicine typically begins its effect for acute pain within 30 to 60 minutes of taking a dose. Its peak effect is generally observed within a few hours after administration.


Q: If Aproxen is taken daily for a long time, how long might it take to feel its full effect for chronic conditions like arthritis?

A: While the pain-relieving effects start quickly, official clinical guidelines suggest that the full anti-inflammatory benefits required for managing chronic conditions such as arthritis may take up to one to two weeks of use to be fully evident.


Q: How long does Aproxen stay in the system after the final dose?

A: According to the official prescribing information, Aproxen has a relatively long elimination time, meaning it takes longer for the body to clear. This longer presence in the body is what allows for it to be taken less frequently than some other pain relievers.


Q: What is the risk of stomach ulcers associated with Aproxen use?

A: Regulatory documents include a serious warning about the risk of gastrointestinal (GI) events, including ulceration, bleeding, and perforation, with NSAID use. Official warnings state that the use of NSAIDs has been observed to cause stomach ulcers in some patients, especially with regular use. This risk is reported to increase with higher doses and longer duration of use.


Q: What signs of a severe allergic reaction to Aproxen should a person watch for?

A: Official adverse reaction reports list signs of a severe hypersensitivity (allergic) reaction. These symptoms may include hives, swelling of the face or throat, wheezing or trouble breathing, or the development of a severe skin rash (like Stevens-Johnson Syndrome). These signs are documented as requiring immediate medical evaluation.


Q: Is it true that Aproxen can cause dizziness or drowsiness?

A: Yes, regulatory documentation confirms that dizziness and drowsiness are common side effects reported in clinical trials. Because of these potential effects, regulatory labels note the risk of impaired ability to perform tasks such as driving or operating machinery.


Q: How might long-term use of Aproxen affect kidney health?

A: Official regulatory documents indicate that Aproxen may affect the kidneys by temporarily decreasing blood flow. Long-term use of NSAIDs is associated with potential kidney effects, and official labeling states that use is restricted for individuals with moderate to severe kidney impairment.


Q: Can Aproxen affect blood pressure levels in some people?

A: Yes, official labeling notes that NSAIDs, including Aproxen, may be associated with the onset of new or worsening existing high blood pressure (hypertension). Regulatory documents describe this as a consideration in the drug's cardiovascular risk profile.


Q: What is the official guidance on Aproxen use during the first half of pregnancy?

A: Studies examining the use of Aproxen during the first half of pregnancy have yielded mixed evidence. Official safety information describes the need for special caution and consideration when an NSAID is used after 20 weeks gestation.


Q: Why should Aproxen be avoided in the later stages of pregnancy (after 20 weeks)?

A: A safety warning from the FDA states that NSAID use at or after 20 weeks of pregnancy can cause a condition called oligohydramnios (low amniotic fluid). Regulatory documentation also indicates a potential for problems with the baby's heart or kidneys in later pregnancy.


Q: Is Aproxen safe to use while breastfeeding?

A: Regulatory sources, such as the NIH LactMed database, indicate that Aproxen levels passed into breast milk are low, and most breastfed infants do not experience adverse effects. However, due to its long presence in the body, it is described that alternative medications may be preferred when nursing a newborn or a premature infant.


Q: Can Aproxen be used for pain and fever in children?

A: Official information indicates that certain prescription and over-the-counter formulations of Aproxen are approved for use in children over 12 years of age. The safety and efficacy for use in children under 12 years of age is generally not established for most formulations.


Q: Can Aproxen be taken alongside acetaminophen (Tylenol)?

A: Official information indicates that Aproxen and acetaminophen (Tylenol) belong to different drug classes and do not have a documented adverse interaction. The main interaction warnings concern combining Aproxen with other NSAIDs or aspirin.


Q: How do SSRI antidepressants interact with Aproxen?

A: Regulatory prescribing information lists the concomitant use of Aproxen with Selective Serotonin Reuptake Inhibitors (SSRIs) as a risk factor. This combination is associated with an increased risk of gastrointestinal bleeding.


Q: Why is Aproxen sometimes combined with a stomach-protecting medicine for long-term use?

A: Due to the potential for Aproxen to cause stomach ulcers and bleeding, especially with long-term or high-dose use, some official guidelines describe co-prescribing a stomach-protecting medicine. This is typically a drug like a proton pump inhibitor (PPI) that is intended to help shield the stomach lining from damage.


Q: Is Aproxen recommended for managing pain from menstrual cramps?

A: Yes, official regulatory indications list Aproxen as an approved treatment for the management of pain associated with primary dysmenorrhea (menstrual cramps).


Q: Are there specific forms of arthritis, like gout or ankylosing spondylitis, that Aproxen is used for?

A: Official indications confirm that Aproxen is approved for the management of the signs and symptoms of several specific inflammatory conditions. These include rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, and acute gout.


Q: What are the signs of liver injury that may be associated with Aproxen?

A: While serious liver injury is reported as rare, official safety information lists signs that warrant medical evaluation. These include: nausea, upper stomach pain, itching, flu-like symptoms, dark urine, or jaundice (yellowing of the skin or eyes).


Q: Is Aproxen one of the medications that can cause ringing in the ears (tinnitus)?

A: Yes, official adverse reaction reports list tinnitus (a persistent ringing or buzzing in the ears) as a reported side effect of Aproxen.


Q: What is the general advice about taking Aproxen if someone is on a low sodium diet?

A: Since Aproxen is often formulated as Naproxen Sodium, it contains salt. Regulatory guidance requires that if the amount of sodium per dose exceeds a certain threshold, the label must include a warning advising the person to consult with a healthcare professional if they are on a sodium-restricted diet.


Q: Is Aproxen considered to be addictive or habit-forming?

A: No, Aproxen is a Nonsteroidal Anti-inflammatory Drug (NSAID). It is not classified as an opioid or a controlled substance by regulatory agencies, and therefore, it is not considered addictive or habit-forming.


Q: Can Aproxen cause changes to vision?

A: Official adverse reaction reports indicate that in rare instances, blurred or double vision has been reported with NSAIDs, including Aproxen. If a person notices a change in vision, medical evaluation is advised.


Q: What makes Aproxen useful for the treatment of bursitis or tendinitis?

A: Aproxen is officially indicated for the relief of the signs and symptoms of both bursitis and tendinitis. Its usefulness is due to its documented effect in treating the pain and reducing the inflammation associated with these musculoskeletal conditions.

How should Aproxen be stored and disposed of?

Storage and Disposal Requirements for Aproxen

Official regulatory labeling outlines strict conditions for the storage and disposal of Aproxen (Naproxen/Naproxen Sodium) to maintain product stability and safety.

Required Storage Conditions

Condition Requirement
Temperature Store at controlled room temperature: 20 C to 25 C (68 F to 77 F). Avoid excessive heat above 40 C (104 F).
Protection The medicine must be protected from light and high humidity.
Packaging Keep the product in its original, tightly closed container to preserve stability.
Child Safety It is mandatory to keep this medicine out of the sight and reach of children and store it locked up.

Disposal Instructions

Expired or unused Aproxen should not be disposed of via household waste or wastewater. Disposal must follow local regulations for pharmaceutical waste handling; contact a pharmacist or waste disposal facility for guidance on approved methods.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Aproxen found in:

A-Z Index: